Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test 'Trained' tumor cells as cancer vaccine in major trial

NCT ID NCT00722228

Summary

This study is testing a personalized cancer vaccine made from a patient's own tumor cells. The cells are modified in a lab to train the immune system to attack the cancer, then injected back into the patient. The trial is for adults with advanced cancers that have spread and who have already tried chemotherapy, with the goal of helping them live longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hadassah Medical Organization

    RECRUITING

    Jerusalem, 91120, Israel

    Contact

Conditions

Explore the condition pages connected to this study.